This is a guest post by Moriah Pollock-Hawthorne, Haverford University.I was an intern at NICE International and an American university student with aspirations to become a doctor. In an effort to learn about universal health coverage and experience a single-payer healthcare system in action, I came

http://wapo.st/K7vTBPWhat’s in a name? That’s a question that experts are wrestling with as they prepare to revise the diagnostic manual that spells out the criteria for addiction and other substance-use problems.The catalyst for this discussion is a set of proposed changes to the Diagnostic and Sta

(Reuters) – Alabama, one of two U.S. states that segregate inmates with HIV from the rest of their prison population, will seek to defend the policy against a class action lawsuit headed to trial in federal court on Monday.The American Civil Liberties Union sued Alabama in 2011 for what the group co

To learn how best to prescribe powerful drugs to children, Congress passed a law in the 1990s that rewarded drug makers for conducting clinical studies involving children. Among the incentives for cooperating companies was a possible six-month extension of protection from generic competition after a

WASHINGTON — Is the world on the verge of ending the AIDS epidemic and creating an AIDS-free generation, even though a cure and a vaccine are still distant hopes?Yes, roared enthusiasts among the nearly 24,000 participants at the 19th International AIDS Conference here last week. Their hopes are bas

Project Consultant Dr. Yot Teerawattananon and Dr. Wanrudee Isaranuwatchai      63191002RM018L0quarantine guideline

Researcher: ภญ.ศิตาพร ยังคง The International Regulation of New Medical Technology: Health Technology Adoption in the European Union, North America, East Asia and in the Developing World

HUMAN genome sequencing is already helping researchers find new treatments for illness. Now an unusual case study suggests that the benefits of sequencing may be enhanced in combination with detailed blood tests.The case involves Michael Snyder, a geneticist who was both the lead author and the subj

An aim of this study is to describe quantitatively and qualitatively progression and findings from the HTA topic selection process recently developed by HITAP. The process involves potential users of HTA information; namely (1) third party payers (public health insurers), (2) national health care program managers (Ministry of Public Health’s Depa

This course was organised at the request of Prof. Rakesh Aggarwal, the Director of JIPMER and Prof. Gagandeep Kang, the Executive Director of THSTI and Professor at the Christian Medical College (CMC) in Vellore, India. The main objective of the course was to build technical capacity of stakeholders